NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank663Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth135ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration845EPS acceleration at or above zero, largest first.
- High return on equity380ROE at least 25%, highest first.
- NYSE only362The same ranking with NYSE listings only.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| ACRACRES Commercial Realty Corp.NYSE | — | — | -4.1% | — | — | 2026-06-30Filed 2026-08-04 |
| ACREAres Commercial Real Estate CorpNYSE | — | — | 14.3% | -0.9% | -8.0% | 2026-06-30Filed 2026-08-04 |
| ACRSAclaris Therapeutics, Inc.NASDAQ | — | — | -8.3% | -60.8% | -921.5% | 2026-06-30Filed 2026-08-06 |
| ACRVAcrivon Therapeutics, Inc.NASDAQ | — | — | — | -85.6% | — | 2026-06-30Filed 2026-08-12 |
| ACTEnact Holdings, Inc.NASDAQ | — | 3.4 pp | 4.1% | — | — | 2026-06-30Filed 2026-08-06 |
| ACTGACACIA RESEARCH CORPNASDAQ | — | — | 123.6% | -2.8% | -5.4% | 2026-06-30Filed 2026-08-06 |
| ACTUACTUATE THERAPEUTICS, INC.NASDAQ | — | — | — | -2067.8% | — | 2026-06-30Filed 2026-08-14 |
| ACXPAcurx Pharmaceuticals, Inc.NASDAQ | — | — | — | -92.1% | — | 2026-06-30Filed 2026-08-13 |
| ADACAmerican Drive Acquisition CoNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
| ADAMADAMAS TRUST, INC.NASDAQ | — | — | — | -0.1% | — | 2026-09-30Filed 2026-10-30 |
| ADBTAdvasa Holdings, Inc.NASDAQ | — | — | 23.3% | — | — | 2026-06-30Filed 2026-08-12 |
| ADCTADC Therapeutics SANYSE | — | — | 3.0% | — | -125.1% | 2026-06-30Filed 2026-08-13 |
| ADGMAdagio Medical Holdings, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-11 |
| ADIGADI GLOBAL DISTRIBUTION INC.NYSE | — | — | 0.7% | — | — | 2026-07-04Filed 2026-08-13 |
| ADILAzora Therapeutics, Inc. (DE)NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-10-21 |
| ADNTAdient plcNYSE | — | — | 5.0% | 2.8% | 0.3% | 2026-06-30Filed 2026-08-05 |
| ADPAUTOMATIC DATA PROCESSING INCNASDAQ | — | — | 6.1% | 88.9% | 20.3% | 2026-09-30Filed 2026-10-30 |
| ADPTAdaptive Biotechnologies CorpNASDAQ | — | — | 21.5% | -44.7% | -20.7% | 2026-06-30Filed 2026-08-04 |
| ADTADT Inc.NYSE | — | — | 2.0% | 17.6% | 11.9% | 2026-06-30Filed 2026-07-30 |
| ADTNADTRAN Holdings, Inc.NASDAQ | — | — | 6.1% | -20.1% | -2.3% | 2026-06-30Filed 2026-08-04 |
| ADVAdvantage Solutions Inc.NASDAQ | — | — | 1.8% | -68.6% | -7.6% | 2026-06-30Filed 2026-08-05 |
| ADVBAdvanced Biomed Inc.NASDAQ | — | — | — | 54.4% | — | 2026-06-30Filed 2026-10-13 |
| AEAQActivate Energy Acquisition Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-12 |
| AEBIAebi Schmidt Holding AGNASDAQ | — | — | 78.7% | 2.6% | 1.1% | 2026-06-30Filed 2026-08-13 |
| AEEAMEREN CORPNYSE | — | -7.7 pp | -5.8% | — | — | 2026-06-30Filed 2026-08-03 |
| AEHRAEHR TEST SYSTEMSNASDAQ | — | — | 33.7% | -3.2% | -14.3% | 2026-05-29Filed 2026-07-27 |
| AEIAlset Inc.NASDAQ | — | — | -10.0% | -35.5% | -951.4% | 2026-06-30Filed 2026-08-14 |
| AEISADVANCED ENERGY INDUSTRIES INCNASDAQ | — | -52.0 pp | 30.0% | — | — | 2026-06-30Filed 2026-08-03 |
| AEMDAETHLON MEDICAL INCNASDAQ | — | — | — | -133.4% | — | 2026-06-30Filed 2026-08-13 |
| AENTALLIANCE ENTERTAINMENT HOLDING CORPNASDAQ | — | — | 17.7% | 11.2% | 1.1% | 2026-06-30Filed 2026-09-10 |
| AEOAMERICAN EAGLE OUTFITTERS INCNYSE | — | — | 7.5% | 19.1% | 5.9% | 2026-08-01Filed 2026-09-10 |
| AEONAEON Biopharma, Inc.NYSE | — | — | — | — | — | 2026-06-30Filed 2026-08-12 |
| AERTAeries Technology, Inc.NASDAQ | — | — | 43.0% | — | — | 2026-06-30Filed 2026-08-10 |
| AESAES CORPNYSE | — | — | 19.9% | 37.9% | 14.3% | 2026-06-30Filed 2026-08-04 |
| AESIAtlas Energy Solutions Inc.NYSE | — | — | 1.6% | — | — | 2026-06-30Filed 2026-08-05 |
| AESPAeon Acquisition I Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-18 |
| AEVAAeva Technologies, Inc.NASDAQ | — | — | 11.3% | -117.8% | -150.1% | 2026-06-30Filed 2026-08-06 |
| AEXAAmerican Exceptionalism Acquisition Corp. ANYSE | — | — | — | — | — | 2026-06-30Filed 2026-08-12 |
| AEYEAUDIOEYE INCNASDAQ | — | — | 7.2% | -59.9% | -7.1% | 2026-09-30Filed 2026-10-26 |
| AFCGAdvanced Flower Capital Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| AFJKAimei Health Technology Co., Ltd.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| AFRMAffirm Holdings, Inc.NASDAQ | — | — | 26.4% | 35.2% | 133.6% | 2026-06-30Filed 2026-08-27 |
| AGENAGENUS INCNASDAQ | — | — | 34.4% | — | — | 2026-06-30Filed 2026-08-07 |
| AGIGABUNDIA GLOBAL IMPACT GROUP, INC.NYSE | — | — | 304.4% | -126.6% | -1441.4% | 2026-06-30Filed 2026-08-07 |
| AGIOAGIOS PHARMACEUTICALS, INC.NASDAQ | — | — | 259.3% | -40.1% | -418.2% | 2026-06-30Filed 2026-07-30 |
| AGLagilon health, inc.NYSE | — | — | 7.2% | -102.1% | -3.9% | 2026-06-30Filed 2026-08-05 |
| AGNCAGNC Investment Corp.NASDAQ | — | — | — | 0.9% | — | 2026-09-30Filed 2026-10-29 |
| AGNTAGNT, Inc.NASDAQ | — | — | 10.7% | -6.1% | -0.3% | 2026-06-30Filed 2026-08-04 |
| AGPUAXE COMPUTE INC.NASDAQ | — | — | — | -744.6% | — | 2026-06-30Filed 2026-08-14 |
| AGQProShares Trust IINYSE | — | — | 57.1% | 8.5% | — | 2026-06-30Filed 2026-08-07 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-04. Source: FRED / Federal Reserve.